Author:
Mita Monica M,Sargsyan Liza,Mita Alain C,Spear Matt
Subject
Pharmacology (medical),Pharmacology,General Medicine
Cited by
52 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Discovery, synthesis, activities, structure–activity relationships, and clinical development of combretastatins and analogs as anticancer drugs. A comprehensive review;Natural Product Reports;2024
2. Discovery of novel (E)-1-methyl-9-(3-methylbenzylidene)-6,7,8,9-tetrahydropyrazolo[3,4-d]pyrido[1,2-a]pyrimidin-4(1H)-one as DDR2 kinase inhibitor: Synthesis, molecular docking, and anticancer properties;Bioorganic Chemistry;2023-06
3. The Cancer Stem Cell and Tumour Progression;Evolutionary Dynamics of Malignancy;2023
4. Novel pyrazolo[3,4-d]pyrimidines as potential anticancer agents: Synthesis, VEGFR-2 inhibition, and mechanisms of action;Biomedicine & Pharmacotherapy;2022-12
5. Anticancer peptides mechanisms, simple and complex;Chemico-Biological Interactions;2022-12